18635-55-7

Basic information

• Product Name: H-GLY-ARG-OH
• Synonyms: H-GLY-ARG-OH;GLY-L-ARG-OH;(S)-2-(2-aminoacetamido)-5-guanidinopentanoic acid;REF DUPL: H-Gly-Arg-OH;Glycylarginine;Glycyl-L-arginine;NSC 334212
• CAS NO: 18635-55-7
• Molecular Formula: C₈H₁₇N₅O₃
• Molecular Weight: 231.25
• Mol File: 18635-55-7.mol
• Article Data: 3

Chemical Properties

• Appearance: /
• Density: 1.51
• Refractive Index: 1.62
• Storage Temp.: -15°C
• CAS DataBase Reference: H-GLY-ARG-OH(CAS DataBase Reference)
• NIST Chemistry Reference: H-GLY-ARG-OH(18635-55-7)
• EPA Substance Registry System: H-GLY-ARG-OH(18635-55-7)

Safety Data

• Hazardous Substances Data: 18635-55-7(Hazardous Substances Data)

Usage

General Description

H-gly-arg-oh is a peptide consisting of the amino acids glycine, arginine, and a hydroxyl group. Glycine is the simplest amino acid and is involved in the synthesis of nucleic acids and bile salts, while arginine is involved in the urea cycle and the production of nitric oxide. The hydroxyl group is a functional group that can participate in various chemical reactions and is commonly found in alcohols and carbohydrates. Together, these chemicals play important roles in biological processes such as protein synthesis, metabolism, and signal transduction.

InChI:InChI=1/C8H17N5O3/c9-4-6(14)13-5(7(15)16)2-1-3-12-8(10)11/h5H,1-4,9H2,(H,13,14)(H,15,16)(H4,10,11,12)

Upstream product

• 2149-70-4 N-nitro-L-arginine 
• 74-79-3 L-arginine 
• 7647-01-0 hydrogenchloride 
• 35146-46-4 Z-glycyl-N^G-nitro-L-arginine 
• 64-19-7 acetic acid 
• 29971-11-7 N^α-(N-benzyloxycarbonyl-glycyl)-L-arginine 

Downstream Products

• 74-79-3 L-arginine 
• 56-40-6 glycine 

Relevant articles and documents

Identification and characterization of prokaryotic dipeptidyl-peptidase 5 from porphyromonas gingivalis

Porphyromonas gingivalis, a Gram-negative asaccharolytic anaerobe, is a major causative organism of chronic periodontitis. Because the bacterium utilizes amino acids as energy and carbon sources and incorporates them mainly as dipeptides, a wide variety of dipeptide production processes mediated by dipeptidyl-peptidases (DPPs) should be beneficial for the organism. In the present study, we identified the fourth P. gingivalis enzyme, DPP5. In a dpp4-7-11-disrupted P. gingivalis ATCC 33277, a DPP7-like activity still remained. PGN-0756 possessed an activity indistinguishable from that of the mutant, and was identified as a bacterial orthologue of fungal DPP5, because of its substrate specificity and 28.5% amino acid sequence identity with an Aspergillus fumigatus entity. P. gingivalis DPP5 was composed of 684 amino acids with a molecular mass of 77,453, and existed as a dimer while migrating at 66 kDa on SDS-PAGE. It preferred Ala and hydrophobic residues, had no activity toward Pro at the P1 position, and no preference for hydrophobic P2 residues, showed an optimal pH of 6.7 in the presence of NaCl, demonstrated Km and kcat/Km values for Lys-Ala-MCA of 688 μM and 11.02 μM-1 s-1, respectively, and was localized in the periplasm. DPP5 elaborately complemented DPP7 in liberation of dipeptides with hydrophobic P1 residues. Examinations of DPP- and gingipain gene-disrupted mutants indicated that DPP4, DPP5, DPP7, and DPP11 together with Arg- and Lys-gingipains cooperatively liberate most dipeptides from nutrient oligopeptides. This is the first study to report that DPP5 is expressed not only in eukaryotes, but also widely distributed in bacteria and archaea.

Remedies and/or preventives for conformational diseases

The present invention provides a therapeutic and/or prophylactic agent against conformational diseases. An object of the present invention is to provide a therapeutic and/or prophylactic agent against conformational diseases, which comprise, as an active ingredient, a neuropeptide or a pharmacologically acceptable salt thereof having neuroprotective action.